Simultaneous Treatment For HIV/TB Improves Survival Of Co-Infected, Study Says

Center for Global Health Policy’s “Science Speaks”: Concurrent treatment for HIV/TB co-infection breaks up ‘deadly alliance’
In a guest post, Martha P. Skiles, a research associate at MEASURE Evaluation at the University of North Carolina at Chapel Hill, and Stephanie Mullen, team leader at MEASURE Evaluation and senior M&E adviser at John Snow Inc., discuss “how current data from Ukraine show promise for patients co-infected with TB and HIV.” They write, “In the study of TB and HIV service integration, data reviewed from patients presenting with TB found that early initiation of antiretroviral treatment for those co-infected with HIV, improved survival” (3/26).